Cite
Intravenous immunoglobulin treatment in autoimmune neurological disorders: pilot study on early effects on patients' quality of life.
MLA
Padua, Luca, et al. “Intravenous Immunoglobulin Treatment in Autoimmune Neurological Disorders: Pilot Study on Early Effects on Patients’ Quality of Life.” Journal of the Peripheral Nervous System, vol. 9, no. 1, Mar. 2004, pp. 3–6. EBSCOhost, https://doi.org/10.1111/j.1085-9489.2004.09102.x.
APA
Padua, L., Aprile, I., Caliandro, P., Padua, R., Mazza, S., & Tonali, P. (2004). Intravenous immunoglobulin treatment in autoimmune neurological disorders: pilot study on early effects on patients’ quality of life. Journal of the Peripheral Nervous System, 9(1), 3–6. https://doi.org/10.1111/j.1085-9489.2004.09102.x
Chicago
Padua, Luca, Irene Aprile, Pietro Caliandro, Roberto Padua, Salvatore Mazza, and Pietro Tonali. 2004. “Intravenous Immunoglobulin Treatment in Autoimmune Neurological Disorders: Pilot Study on Early Effects on Patients’ Quality of Life.” Journal of the Peripheral Nervous System 9 (1): 3–6. doi:10.1111/j.1085-9489.2004.09102.x.